AOD-9604 5 mg vial
- RUO$38Listed price · deal not verifiedCOA tested Jun 16, 2026
- Oasis Peptides$47Listed price · deal not verifiedCOA tested Jun 15, 2026
- Evolve Peptides$49.90Listed priceCOA tested Jan 23, 2026
AOD-9604 is a synthetic fragment modeled on part of human growth hormone and studied mainly in metabolic and obesity research.
Also known as aod · aod 9604 · aod-9604 · aod9604
Current picks · Nov 14, 2026
Up to three of the lowest effective prices per exact product among vendors that passed the trust floor, were in stock and checked within 72 hours, and have a COA on file for that product and strength tested within 12 months. Affiliate relationships never affect picks or their order.
Same format. Same amount.
4 of 4 exact products have at least one pick. Vendor counts reflect the current price observations. Testing records for every vendor and strength: AOD-9604 COAs →
Historical market context
Historical market low and median per mg across recorded offers. These market summaries are separate from our exact-product comparisons.
History updated Sep 21, 2026. Vendor coverage, package sizes, product forms and promotions can vary over time. Use exact-product comparisons for current listed prices; historical market prices do not establish vendor trust.
| Date | Low /mg | Median /mg | Vendors | Offers |
|---|---|---|---|---|
| $3.60 | $9.00 | 71 | 94 | |
| $3.60 | $9.00 | 69 | 91 | |
| $3.60 | $9.54 | 48 | 67 | |
| $1.08 | $8.81 | 31 | 52 |
What it is
PubChem describes AOD-9604 as an analog of the lipolytic domain of human growth hormone. It is a fragment and should not be treated as equivalent to full-length somatropin.
This label describes the available research record, not whether the compound is safe or effective for an individual.
Research context
The indexed record includes metabolic discussion, but the bounded search found no matched registered U.S. study under the exact name. Mechanistic expectations and animal findings do not establish meaningful human weight-loss outcomes.
Search indexed research for this compound ↗Market context
AOD-9604 is commonly sold or discussed for appetite, weight management, glucose control, and metabolic research. That describes market demand, not proof that the compound is safe or effective.
Market demand and online discussion do not establish product quality, safety, or effectiveness.Vendor directory
Grades describe the vendor record overall, not a test of every product. Lowest prices are effective single-package prices across formats; open a comparison for the exact product.
| Vendor | Grade | Offers | In stock | Lowest effective package |
|---|---|---|---|---|
| Amino Science | Grade A- | 1 | 1 | $77.99 · 5 mg vialObserved Nov 14, 2026 |
| EZ Peptides | Grade A- | 2 | 2 | $38 · 2 mg vialObserved Nov 14, 2026 |
| Nura Peptide | Grade A- | 1 | 1 | $40 · 5 mg vialEarlier observation Oct 9, 2026 |
| Polaris Peptides | Grade A- | 1 | 1 | $40 · 2 mg vialObserved Nov 14, 2026 |
| Ascension Peptides | Grade A- | 1 | 1 | $55 · 5 mg vialObserved Nov 14, 2026 |
| Evolve Peptides | Grade A- | 2 | 2 | $49.90 · 5 mg vialObserved Nov 14, 2026 |
| Orbitrex Peptides | Grade A- | 1 | 0 | $59.99 · 5 mg vialObserved Nov 14, 2026 · out of stock |
| Puratek Peptides | Grade A- | 1 | 1 | $39.95 · 5 mg vialObserved Nov 14, 2026 |
| Bulk Peptide Supply | Grade B+ | 2 | 2 | $25 · 5 mg vialObserved Nov 14, 2026 |
| Ameano Peptides | Grade B+ | 2 | 2 | $38 · 2 mg vialObserved Nov 14, 2026 |
| Blue Ridge Peptides | Grade B+ | 1 | 1 | $35 · 5 mg vialObserved Nov 14, 2026 |
| Glacier Aminos | Grade B+ | 1 | 1 | $89.99 · 10 mg vialObserved Nov 14, 2026 |
| Alpha Peps | Grade B+ | 2 | 2 | $25 · 10 mg vialObserved Nov 14, 2026 |
| Alpha Pro Peptides | Grade B+ | 1 | 1 | $59.99 · 5 mg vialObserved Nov 14, 2026 |
| Prime Lab Peptides | Grade B+ | 1 | 1 | $50 · 5 mg vialEarlier observation Oct 28, 2026 |
| Oasis Peptides | Grade B+ | 1 | 1 | $47 · 5 mg vialObserved Nov 14, 2026 |
| Oros Research | Grade B+ | 1 | 1 | $39.99 · 5 mg vialEarlier observation Oct 29, 2026 |
| Core Peptides | Grade B+ | 1 | 1 | $41 · 5 mg vialEarlier observation Oct 20, 2026 |
| RIVN Peptides | Grade B+ | 1 | 1 | $54.99 · 5 mg vialObserved Nov 14, 2026 |
| Simple Peptide | Grade B | 2 | 2 | $45 · 5 mg vialEarlier observation Sep 27, 2026 |
| Coffee and Peppers | Grade B | 1 | 1 | $64.99 · 10 mg vialEarlier observation Oct 4, 2026 |
| RUO | Grade B | 1 | 1 | $38 · 5 mg vialObserved Nov 14, 2026 |
| NuLife Peptides | Grade B | 1 | 1 | $45 · 5 mg vialEarlier observation Oct 17, 2026 |
| Premier Bio Labs | Grade A- | 1 | 1 | $305 · 5 mg vial · pack of 10Earlier observation Sep 21, 2026 |
| Amino Amigos | Grade B+ | 1 | 1 | $38 · 2 mg vialEarlier observation Nov 13, 2026 |
| NextGen Peptides | Grade B | 1 | 0 | $200 · 5 mg vial · pack of 10Observed Nov 14, 2026 · out of stock |
| NextechLabs | Grade C | 1 | 1 | $40 · 5 mg vialEarlier observation Oct 4, 2026 |
| AIO Peptides | Not graded | 1 | 1 | $36.80 · 5 mg vialObserved Nov 14, 2026 |
| Astro Peptides | Not graded | 1 | 1 | $45 · 5 mg vialObserved Nov 14, 2026 |
| Nova Life Peptides | Not graded | 1 | 1 | $45 · 5 mg vialObserved Nov 14, 2026 |
| Pharma Grade Peptides | Not graded | 1 | 1 | $79.99 · 10 mg vialObserved Nov 14, 2026 |
| Pura Peptides | Not graded | 1 | 1 | $49.99 · 5 mg vialObserved Nov 14, 2026 |
28 tracked vendors list AOD-9604 without a current offer: Peptide Plugs (Grade A-), Southern Aminos (Grade A-), Voltera Sciences (Grade B+), Panda Peptides (Grade B+), Peptide Partners (Grade B+), Peptide Crafters (Grade B+), SaiyanMed (Grade B+), TCore Biotech (Grade B), Ion Peptides (Grade B), Paramount Peptides (Grade B), Chameleon Peptides (Grade B), Nationwide Peptides (Grade B+), VAYN (Grade B), Prime Peptides (Grade B), Blank Peptides (Grade B), Royal Peptides (Grade B), Vital Core Research (Grade B), Mile High Compounds (Grade B), Peptidology (Grade C), Oath Research (Grade C), Swiss Chems (Grade C), American Peptide Research (Not graded), Atomik Labz (Not graded), Northline Labs (Not graded), Nuscience Peptides (Not graded), Planet Peptide (Not graded), Skye Peptides (Not graded), Tydes (Not graded).
Sources and review
Last editorial review: Aug 30, 2026. Sources support the compound guide only and do not affect vendor grades.